Stocks and Investing Stocks and Investing
Thu, October 22, 2020
Wed, October 21, 2020
Tue, October 20, 2020
Mon, October 19, 2020

Joshua Jennings Maintained (ABT) at Buy with Decreased Target to $113 on, Oct 19th, 2020


Published on 2024-10-27 14:24:35 - WOPRAI, Joshua Jennings
  Print publication without navigation


Joshua Jennings of TD Cowen, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $115 to $113 on, Oct 19th, 2020.

Joshua has made no other calls on ABT in the last 4 months.



There are 10 other peers that have a rating on ABT. Out of the 10 peers that are also analyzing ABT, 1 agrees with Joshua's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $110 on, Friday, July 17th, 2020


These are the ratings of the 9 analyists that currently disagree with Joshua


  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $125 on, Friday, October 9th, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy and Held Target at $115 on, Monday, September 28th, 2020
  • Mike Polark of "Wolfe Research" Initiated at Buy and Held Target at $124 on, Friday, September 11th, 2020
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $136 on, Monday, August 31st, 2020
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $130 on, Friday, August 28th, 2020
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $112 on, Thursday, August 27th, 2020
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Thursday, August 27th, 2020
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $125 on, Thursday, July 23rd, 2020
  • John Sourbeer of "UBS" Maintained at Strong Buy with Increased Target to $110 on, Friday, July 17th, 2020